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HIGHLIGHTS  
 
- Infralimbic stimulation increases basal plasma levels of corticosterone. 
 
- Environmental enrichment enhances the effects of infralimbic stimulation.  
 
-Infralimbic inhibition reduces stress-induced corticosterone in control animals. 
 
- Infralimbic cortex contributes to HPA activation during stress and aversive memory. 
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ABSTRACT 
 
The aim of the present study was to investigate the effects of the stimulation and 
inhibition of the ventral part of the medial prefrontal cortex (infralimbic cortex) on basal 
and stress-induced plasma levels of corticosterone and on the acquisition of aversive 
memory in animals maintained in control and environmental enrichment (EE) 
conditions. Intracortical microinjections of the GABAA antagonist picrotoxin and 
agonist muscimol were performed in male Wistar rats to stimulate and inhibit, 
respectively, the activity of the infralimbic cortex. Injections were performed 60 min 
before foot shock stress and training in the inhibitory avoidance task. Picrotoxin 
injections into the infralimbic cortex increased basal plasma levels of corticosterone. 
These increases were higher in EE rats which suggest that EE enhances the control 
exerted by infralimbic cortex over the hypothalamus-pituitary-adrenal (HPA) axis and 
corticosterone release. Muscimol injections into the infralimbic cortex reduced the 
stress-induced plasma levels of corticosterone and the retention latency 24 h after 
training in the inhibitory avoidance performance in control and EE animals, 
respectively. These results further suggest that the infralimbic cortex is required for the 
activation of the HPA axis during stress and for the acquisition of contextual aversive 
memories.      
 
 
 
Keywords: prefrontal cortex, picrotoxin, muscimol, stress, corticosterone, emotional 
memory.  
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1. INTRODUCTION 
 
Growing evidence shows that the prefrontal cortex (PFC) regulates the activation of the 
Hypothalamus-Pituitary-Adrenal (HPA) axis and the release of corticosterone (cortisol 
in humans) in response to stress [1, 2]. Yet how the PFC exerts this regulation is a 
matter of debate. Previous studies in rodents suggest that the dorsal (prelimbic) and 
ventral (infralimbic) parts of the medial PFC exert opposite control on the HPA axis 
activity and plasma levels of corticosterone in response to stress [2-4]. However, most 
pharmacological and lesion studies are limited to the dorsal part of the medial PFC or 
do not distinguish between the dorsal and ventral parts [5-8] and, therefore, the role 
played by the infralimbic cortex in the regulation of the HPA axis and corticosterone 
concentrations is still uncertain. A dysfunctional regulation of the HPA axis as well as 
other limbic areas by the infralimbic cortex (ventral medial PFC in humans) is 
associated with stress mal adaptation and stress-related disorders [9-12]. 
 
Infralimbic cortex also contributes to stress adaptation by modulating emotional 
learning and memory [13, 14]. Studies focused on the prelimbic cortex suggest a 
negative control by this prefrontal area on the acquisition of contextual fear-related 
memories [6, 8]. However, and despite its well established role in extinction memory 
[15, 16], few studies have investigated whether infralimbic cortex contributes to the 
acquisition of aversive memory. In fact, lesion studies report controversial results 
suggesting that infralimbic cortex facilitates [13] or does not change [17] the acquisition 
of contextual aversive memories.  
 
Animals housed in an enriched environment show a lower reactivity to stress that is 
reflected by a reduced anxiety and a faster habituation to novelty in the open field [18-
23]. These behavioural effects produced by environmental enrichment (EE) are, in part, 
mediated by changes in the activity of the HPA axis and the release of corticosterone 
[24]. Studies from our laboratory and others suggest that changes in the activity of the 
PFC, presumably infralimbic cortex, explain the reduced reactivity to stress that is 
observed in enriched animals [9, 25, 26].  
 
The aim of the present study is twofold. Firstly, to investigate the effects of the 
stimulation and inhibition of the infralimbic cortex on basal and stress-induced plasma 
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levels of corticosterone, and on the acquisition of aversive memory evaluated by the 
inhibitory avoidance task. And secondly, to investigate whether housing animals in EE 
changes the role played by the infralimbic cortex in these variables. Intracortical 
microinjections of the GABAA antagonist picrotoxin and the GABAA agonist muscimol 
were performed to stimulate and inhibit, respectively, the activity of the infralimbic 
cortex [8]. In this study we also evaluate whether EE changes spontaneous motor 
activity in the open field as observed in previous studies from our laboratory [20]. 
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2. Methods 
 
2.1. Animals and housing conditions 
Male Wistar rats (3 months of age) (Harlan, Netherland) were housed in two different 
conditions during 2 months: the environmental enrichment (EE) group (weight 486 ± 5 
g, n= 48) was housed in large cages (120 x 100 x 52 cm) 10-12 animals per cage, 
containing 2 running wheels, a rearrangeable set of plastic tunnels, a elevated platform, 
and toys changed every 5-6 days. The control group (weight 504 ± 6 g, n= 47) was 
housed in standard cages (35 cm x 50 cm x 20 cm) 2 animals per cage. Animals were 
provided with food and water ad libitum and maintained in a temperature-controlled 
room (22 ± 2 ºC) under an inverted light/dark cycle (lights on 20:00). The experiments 
were carried out during the dark phase of the cycle (15:00 - 18:00). All experiments 
were carried out in our laboratory at the University Complutense of Madrid following 
the Spanish regulations for the protection of laboratory animals (RD1201/2005; RD 
53/2013).  
 
2.2. Spontaneous motor activity 
Spontaneous motor activity of the animals was evaluated in open field arenas (MED 
Associates Inc., St. Albans, USA). The open field apparatus consisted of a Plexiglas box 
(80 x 80 x 45 cm) equipped with two horizontal rows of eight infrared light sensitive 
photocell beams located at 5 and 15 cm, respectively, from the basement, allowing the 
detection of horizontal and vertical (rearing) motor activity. Interruptions of the 
photocell beams (activity counts) were registered automatically by computer software 
connected to the open field apparatus (MED Associates Inc., St. Albans, USA). Open 
field arena was wiped with 70 % alcohol between rats [20]. 
 
2.3. Microinjections into the infralimbic cortex   
Three-five days after being tested in the open field, animals were anesthetized with 
equithesin (2.5 mg/kg, i.p.) and stereotaxically implanted in the brain with bilateral 
guide-cannulae to reach the infralimbic region of the ventromedial PFC using the 
following coordinates from bregma: + 2.5 mm rostral, +0.7 mm medial and -3.5 mm 
from the top of the skull and with the incisive bar set at -3 mm [27]. Guide cannulae, 
23-gauge stainless-steel (PlasticsOne, Roanoke, VA, USA) were fixed to the skull 
surface with dental acrylic and three stainless-steel anchorage screws (Agntho´s, 
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Stockholm, Sweden). Dummy cannulae, 28-gauge stainless-steel, were inserted into the 
guide to keep it clean and prevent occlusion. Six-seven days after surgery bilateral 
injections into the infralimbic cortex were performed by means of injection cannulae, 
28-gauge stainless-steel, protruding 1 mm below the tip of the guide and attached to a 
micropump (Harvard Apparatus, Holliston, MA, USA) at a flow rate of 0.25 µl per 
minute. A total volume of 0.25 µl per side was injected maintaining the injection 
cannulae in place for 60 seconds to allow the diffusion of the drug or vehicle. Slow flow 
rate and low volume injections try to avoid diffusion of the drug to neighbour brain 
regions. The animals received the microinjections in their home cages 60 min before 
collecting blood samples (see below) to minimize the effects of the injection procedure 
on corticosterone plasma levels. In addition, a sham injection was performed the day 
before experiments in order to habituate animals to the injection procedure.  
 
The GABAA receptor antagonist picrotoxin 0.20 µg per side (Sigma-Aldrich, Spain) and 
the agonist muscimol 0.25 µg per side (Tocris Bioscience, UK) were freshly dissolved 
in artificial cerebrospinal fluid consisting of (in millimolar): NaCl 137, CaCl2 1.2, KCl 
3, MgSo4 1, NaH2PO4 0.5, Na2HPO4 2, glucose 3, pH= 7.3. The artificial cerebrospinal 
fluid was also used as vehicle. Drugs and doses were selected based on previous studies 
from our laboratory which performed microinjections of these compounds into the 
prelimbic PFC [8]. Microinjections of picrotoxin and muscimol are well-established 
methods to stimulate and inhibit, respectively, transiently the activity of specific brain 
areas [6].  
 
2.4. Inhibitory avoidance task 
Six-seven days after the surgical implantation of guide cannulas, animals were 
evaluated in the inhibitory avoidance apparatus consisting of a shuttle-box divided into 
2 compartments separated by a guillotine door [8, 28]. The starting compartment (light 
compartment, 50 x 50 x 20 cm) was made of white opaque plastic; it had an open roof 
and was well lit by 1 overhead 60W bulb. The shock compartment (dark compartment, 
25 x 25 x 20 cm) was made of black plastic; it had a closed (removable) roof, no 
illumination and an electrified grid floor. The inhibitory avoidance test was carried out 
as follows (Figure 1). On the training day, animals were placed in the light compartment 
and allowed to explore the whole apparatus (guillotine door open) over a period of 300 
seconds (habituation). Five hours later, animals received an infralimbic microinjection 
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of vehicle, muscimol or picrotoxin in their home cages. One hour after the injection 
each rat was re-exposed to the apparatus and latency to enter in the dark compartment 
was measured (training latency). When animals stepped their four paws on the dark 
compartment, the door was lowered and a foot-shock (0.6 mA, 2 s) was delivered. After 
10 seconds animals were removed from the dark compartment and returned to their 
home cages. On the testing day (24 hours after the foot-shock), rats were re-exposed to 
the light compartment and retention of the inhibitory avoidance response was recorded 
as the retention latency, up to a maximum of 600 seconds to enter the dark 
compartment. Animals that reached 600 seconds were removed from the light 
compartment by the experimenter.  
 
2.5. Blood sampling and corticosterone assays 
Blood samples (100 µl) were taken by tail-nick [29]. Animals were gently restrained 
and a small incision with a blade was made 1-2 mm above the tip of the tail. Blood 
samples were collected in heparinized vials in less than 2 minutes during the inhibitory 
avoidance performance. The experimental protocol was as follows (Figure 1): One hour 
after infralimbic microinjections, animals were re-exposed to the inhibitory avoidance 
apparatus and received a foot-shock; immediately after the foot shock, rats were taken 
to their home cages and the first blood sample (basal corticosterone) was collected; 30 
min later, the second blood sample (stress-induced corticosterone) was collected. Vials 
containing blood samples were centrifuged for 10 minutes at 3,000 r.p.m. to obtain 
plasma samples. Plasma samples were storage at -80 ºC until the measure of 
corticosterone levels. 
 
Total corticosterone levels in plasma were measured using a radioimmunoassay kit (MP 
Biomedicals Inc., Solon, OH, USA) following the instructions provided by the 
manufacturer. The inter- and intra-assay coefficient of variance was 6.5 % and 4.4 % 
respectively. 
 
2.6. Histology 
All animals were anesthetized with an overdose of anaesthesia and perfused 
intracardially with 0.9 % saline and 0.2 % heparin followed by 10% formalin. Bilateral 
injections into the infralimbic cortex of methylene blue were performed just before 
intracardial perfusions to better visualize the location of the injection cannulae. The 
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brain was removed and the placement of the injection cannulae was verified in sections 
cut with a cryostat microtome and viewing lens (Figure 2). Animals with incorrect 
placement of injection cannulae were not included in this study.  
 
2.7. Statistical analysis 
The spontaneous motor activity of control and EE rats was evaluated by a two-way 
analysis of the variance (ANOVA) (Group x Time) with repeated measures followed by 
planed comparisons. Three- and two-way ANOVAs with repeated measures followed 
by planed comparisons were use to evaluate the effects of muscimol and picrotoxin on 
basal and stress-induced corticosterone levels. A three-way ANOVA (Group x 
Treatment x Time) was performed to compared control and EE rats. Added to that, two-
way ANOVAs (Treatment x Time) were performed to analyze the effects of treatments 
(Treatment) and stress (Time) in control and EE rats independently. Retention latencies 
24 hours after training in the inhibitory avoidance performance were evaluated by non-
parametric tests. A Kruskal-Wallis test was performed to compare the effects of vehicle, 
muscimol and picrotoxin in control and EE rats. A Mann-withney U test was performed 
to further discriminate drug effects. 
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3. RESULTS 
 
3.1. Spontaneous motor activity in the open field. 
Figure 3 shows the spontaneous motor activity during 60 min in the open field of both 
control and EE rats. The Two-way ANOVA (Group x Time) analysis showed a 
significant effect of Group (F(1,93)= 48.70; p< 0.001), Time (F(11,1023)= 147.60; p< 0.001) 
and Group x Time (F(11,1023)= 12.55; p< 0.001) indicating that EE reduced total 
locomotion. Planned comparisons also showed that locomotion during the first 5 
minutes was higher in EE rats compared to control rats (F(1,93)= 10.51; p= 0.002) [30].  
 
3.2. Effects of muscimol and picrotoxin microinjections into the infralimbic cortex on 
basal and stress-induced concentrations of corticosterone. 
Figure 4 shows the effects of infralimbic injections (60 min before acute stress) of the 
GABAA agonist and antagonist muscimol and picrotoxin, respectively, on basal (A) and 
stress-induced (B) plasma levels of corticosterone in both control and EE rats. A three-
way ANOVA analysis (Group x Treatment x Time) was performed to evaluate 
differences between control and EE rats (Group) on the effects of muscimol and 
picrotoxin (Treatment) as well as foot shock stress (Time) on corticosterone 
concentrations. The three-way ANOVA showed a significant effect of Group (F(1,58)= 
9.23; p= 0.004) and Treatment (F(1,58)= 15.87; p< 0.001), but no Time (F(1,58)= 0.13; 
n.s.). More specifically, planned comparisons showed that picrotoxin injections 
produced a higher increase of basal (F(1,58)= 13.29; p< 0.001) (Fig. 4A) and stress-
induced (F(1,58)= 13.29; p< 0.001) (Fig. 4B) concentrations of corticosterone in EE 
compared to control rats.  
 
Two-way ANOVAs (Treatment x Time) were also performed to evaluate the effects of 
muscimol and picrotoxin (Treatment) as well as foot shock stress (Time) on 
corticosterone concentrations in control and in EE rats independently. In control rats, a 
Two-way ANOVA analysis showed a significant effect of Treatment (F(1,27)= 3.42; p= 
0.047), but not Time (F(1,27)= 0.06; n.s.), and Treatment x Time (F(1,27)= 6.93; p= 0.004). 
More specifically, planned comparison analysis showed that picrotoxin injections 
increased basal concentrations of corticosterone (F(1,27)= 6.56; p= 0.016) (Fig. 4A). This 
analysis also showed that foot shock stress (0.6 mA, 2 s) increased corticosterone 
concentrations in vehicle injected animals (F(1,27)= 6,73; p= 0.015) and that muscimol 
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injections reduced the stress-induced concentrations of corticosterone compared to 
vehicle (F(1,27)= 7.38; p= 0.011) (Fig. 4B). Picrotoxin did not significantly change the 
stress-induced concentrations of corticosterone compared to vehicle (F(1,27)= 3.87; n.s.). 
 
In EE rats, the Two-way ANOVA analysis showed a significant effect of Treatment 
(F(1,31)= 14.46; p< 0.001), but not Time (F(1,31)= 0.08; n.s.) or Treatment x Time (F(1,31)= 
1.97; n.s.). More specifically, planned comparison analysis showed that picrotoxin 
injections increased basal concentrations of corticosterone (F(1,31)= 17.19; p< 0.001) 
compared to vehicle (Fig. 4A). This analysis also showed that foot shock stress (0.6 
mA, 2 s) increased corticosterone concentrations in vehicle injected animals (Fig. 4B) 
although it did not reach statistical significance (F(1,31)=1.36; p= 0.25). Picrotoxin did 
not significantly change the stress-induced concentrations of corticosterone compared to 
vehicle (F(1,31)= 4.12; n.s.). 
 
3.3. Effects of muscimol and picrotoxin microinjections into the infralimbic cortex on 
the inhibitory avoidance performance.  
Figure 5 shows the effects of infralimbic injections (60 min before training) of the 
GABAA agonist and antagonist muscimol and picrotoxin, respectively, on retention 
latencies during the test 24 h after training in the inhibitory avoidance task in both 
control and EE rats. The training latencies, not represented in Figure 5, were: vehicle 
(Control= 12.75 ± 2.35 s; EE= 15.82 ± 5.12 s); Muscimol (Control= 10.50 ± 1.43 s; 
EE= 10.46 ± 2.10 s); Picrotoxin (Control= 11.10 ± 1.89 s; EE= 19.10 ± 7.12 s). 
 
According to the non-parametric analysis Kruskall-Wallis, training latencies were not 
changed by treatment [control (χ2= 1.71; df= 2; n.s.); EE rats (χ2= 3.37; df= 2; n.s.)] or 
housing conditions (χ2= 0.12; df= 1; n.s.). In contrast, this same analysis showed a 
significant effect of treatment in EE (χ2= 10.65; df= 2; p= 0.049), but not control (χ2= 
5.43; df= 2; p= 0.066) rats, on Test retention latencies 24 h after training. More 
specifically, a Mann-Whitey analysis confirmed that muscimol injections into the 
infralimbic cortex reduced the Test retention latency in EE rats compared to vehicle (Z= 
2.22; p= 0.034) (Fig. 5). The effects of muscimol were not statistically different 
between control and EE rats (Z= -0.27; n.s.). 
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4. DISCUSSION 
 
The present study shows that the stimulation and/or inhibition of infralimbic cortex 
modulates basal and stress-induced plasma levels of corticosterone as well as the 
formation of aversive memory. Specifically, the stimulation of infralimbic cortex by 
local injections of picrotoxin increased basal concentrations of corticosterone. This 
effect was enhanced by housing rats in an enriched environment which suggests that EE 
increases the control exerted by infralimbic cortex over the HPA axis. The inhibition of 
infralimbic cortex by local injections of muscimol reduced significantly the increases of 
corticosterone produced by acute stress and the memory acquisition of an aversive event 
(foot shock) in control and EE animals, respectively. These results suggest that 
infralimbic cortex is required for the activation of the HPA axis during acute stress and 
the acquisition of contextual aversive memories.  
 
Despite the evidence showing that the PFC regulates the activity of the HPA axis [2, 
10], previous studies had reported conflicting results regarding the role of the medial 
PFC on basal plasma levels of corticosterone [5, 6] probably because they did not 
distinguish well the prelimbic and infralimbic parts of the medial PFC. As shown, the 
stimulation of infralimbic cortex by local injections of picrotoxin increased the basal 
concentrations of corticosterone. Since picrotoxin injections increase the activity of 
cortical neurons [6], these results suggest that infralimbic cortex exerts a positive 
regulation over the HPA axis through the activation of cortical efferent projections. In 
contrast to picrotoxin, the inhibition of infralimbic cortex by muscimol injections did 
not change basal corticosterone concentrations which indicate that the control over the 
HPA axis by the infralimbic cortex is not tonic.  
 
Housing animals in an enriched environment enhanced the effects of picrotoxin into the 
infralimbic cortex to increase basal plasma levels of corticosterone. These results 
suggest that EE increases the capability of infralimbic cortical outputs to activate the 
HPA axis and release corticosterone. An increase of cortical excitability could account 
for the enhanced activation of the infralimbic cortex found in enriched animals. In fact, 
previous studies have suggested that an increased cortical excitability facilitates whereas 
a decreased cortical excitability reduces, cortical activation involved in fear memory 
[31-33]. 
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Studies from our laboratory and others report that enriched animals show a lower 
reactivity to stress [18, 19, 21, 22, 25, 26]. Based on the present study, we hypothesize 
that an enhanced capability of the infralimbic cortex to control the HPA axis contributes 
to the resilience of enriched animals to stress. In support of this hypothesis, it has been 
shown that EE increases the resilience of animals to social defeat stress by enhancing 
infralimbic cortical outputs to downstream limbic areas [9]. Also, in line with this 
possibility, it has been shown that an increased excitability in the PFC is associated with 
enhanced control over stress [33] and extinction learning [31]. Confirming our previous 
work [20, 23, 30], we also show in this study that EE reduces motor activity in the open 
field suggesting a faster habituation of enriched animals to novel environments (mild 
stress). 
 
The inhibition of infralimbic cortex by muscimol injections reduced the increases of 
plasma levels of corticosterone produced by acute stress (foot shock) in control animals. 
This is in agreement with previous studies which show that infralimbic lesions attenuate 
stress-induced plasma corticosterone [3] and suggest that the infralimbic cortex 
facilitates the HPA axis activation and release of corticosterone produced by acute 
stressful stimuli. Interestingly, previous studies from our laboratory using a similar 
experimental protocol have shown that the stimulation of prelimbic cortex reduces 
stress-induced plasma levels of corticosterone [8]. These results are in agreement with 
the postulated idea that prelimbic and infralimbic cortices play opposite roles in the 
regulation of the HPA axis in response to stress [2, 3]. In fact, an indirect pathway from 
the PFC to the paraventricular nucleus of the hypothalamus has been proposed to 
regulate the HPA axis and the release of corticosterone [3, 34]. It is also shown in this 
study that injections of picrotoxin into the infralimbic cortex seem to increase and 
decrease the stress-induced corticosterone concentrations in EE and control animals, 
respectively. However, given the strong effect produced by picrotoxin increasing basal 
(pre-stress) concentrations of corticosterone, it is difficult to draw any conclusion 
regarding the role of infralimbic stimulation during stress. A similar controversy has 
been reported elsewhere [6]. 
 
Muscimol injections reduced the retention latency 24 h after training in the inhibitory 
avoidance test in control and EE animals (although it did not reach statistical 
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significance in control animals) which indicates that the acquisition of aversive 
memories is facilitated by the infralimbic cortex. These results together with the fact 
that the stimulation of prelimbic cortex inhibits the acquisition of aversive memory [8] 
support the idea of an opposite role of prelimbic and infralimbic cortices in emotional 
processing [35]. Our results are in agreement with studies in which infralimbic lesions 
reduced the retention latency using the same behavioural paradigm [13]. Interestingly, 
as shown here, muscimol injections into the infralimbic cortex also reduced stress-
induced corticosterone concentrations as well as retention latency. These results suggest 
that the infralimbic cortex could contribute to the formation of aversive memory, in 
part, by increasing corticosterone concentrations. The involvement of corticosterone 
increases, immediately after training, enhancing the formation of aversive memory has 
been previously reported [36, 37].  
 
Interestingly, despite increasing corticosterone concentrations, injections of picrotoxin 
into the infralimbic cortex did not increase significantly the retention latency in the 
inhibitory avoidance test in control or EE animals. One possibility to explain this 
apparent contradiction is the timing of corticosterone increases. As shown, picrotoxin 
increased corticosterone concentrations few minutes (probably 15-30 min) before the 
training in the inhibitory avoidance task. This delay matters since studies have shown 
that increases of corticosterone before memory training do not enhance memory 
acquisition or even impair memory [38]. It is also interesting at this respect that other 
factors such as noradrenergic or amygdala activity are required to occur simultaneously 
to corticosterone increases to enhance memory acquisition during the inhibitory 
avoidance task [36].  
 
EE did not significantly modify the stress-induced corticosterone concentrations in 
vehicle and muscimol treated animals. Likewise, the acquisition of aversive memory 
was not significantly changed by EE in none of the treatment groups studied. These 
results indicate that the contribution of the infralimbic cortex to modulate the HPA axis 
during acute stress and the acquisition of emotional memory is not substantially 
changed by EE.  
 
Studies in humans and animals suggest that a reduced activity of infralimbic cortex 
(ventral medial PFC in humans) is associated with stress mal adaptation and stress-
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related disorders (i.e. posttraumatic stress disorder) [11, 12]. In this study we show that 
the infralimbic cortex regulates basal and stress-induced concentrations of 
corticosterone as well as the acquisition of aversive memories. These results further 
suggest that a dysfunctional ventromedial PFC might contribute to stress-related 
disorders through impairing HPA axis regulation and emotional processing. Moreover, 
EE enhances the control that the infralimbic cortex exerts on the HPA axis. A stronger 
interaction between the infralimbic cortex and the HPA axis as well as other limbic 
areas might facilitate the extinction of fear-related memories [12, 31, 39] and protect 
enriched animals to stress-related disorders [9]. 
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FIGURE LEGENDS  
 
Figure 1. Schematic representation of the experimental design used in the present study 
for the behavioural experiments. After evaluating spontaneous motor activity in the 
open field (60 min), animals were implanted with guide cannulas for intracerebral 
injections and 6-7 days after surgery they were tested in the inhibitory avoidance 
apparatus. The foot shock (0.6 mA, 2 s) given during the training test was used to 
evaluate the stress-induced plasma levels of corticosterone in control and EE rats. 
 
Figure 2. Schematic representation showing the approximate location of 
microinjections into the infralimbic cortex of control (left) and EE rats (right) (adapted 
from Paxinos and Watson, 1998).   
 
Figure 3. Temporal profile of the spontaneous motor activity showed by control and EE 
rats exposed for the first time to the open field apparatus. Data (mean ± SEM) represent 
absolutes values of distance traveled (cm). The number of animals is shown in 
parenthesis. Insert shows the total distance traveled for both control (white bar) and EE 
(black bar) rats. **p < 0.01; ***p < 0.001 compared to control rats. 
 
Figure 4. Effects of infralimbic microinjections of muscimol and picrotoxin (60 min 
before foot shock stress; see Figure 1) on basal (A) and stress-induced (B) plasma 
concentrations of corticosterone in control and EE rats. Data (mean ± SEM) are shown 
in ng/ml. Number of animals is shown in parenthesis. #p < 0.05 and ###p < 0.001 
compared to vehicle group; **p < 0.01 and ***p < 0.001 compared to control group; ♦p< 
0.05 compared to basal corticosterone.   
 
Fig. 5 Effects of infralimbic microinjections of muscimol and picrotoxin (60 min before 
training test; see Figure 1) on Test retention latencies 24 h after training in control and 
EE rats. Data (mean ± SEM) represent retention latencies in seconds (s). The number of 
control (vehicle= 8; muscimol= 12; picrotoxin= 10) and EE rats (vehicle= 11; 
muscimol= 13; picrotoxin= 10) are shown in parenthesis. #p < 0.05 compared to vehicle 
EE group. 
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